Your institution may have access to this item. Find your institution then sign in to continue.
Title
In brief.
Abstract
The article presents news briefs related to the biotechnology industry compiled as of May 2006. Merck and Co. Inc. is to pay $400 million for privately held biotechnology firm GlycoFi Inc. that improves drugs by fine-tuning their sugar structures. Stocks of vaccine supplier VaxGen Inc. plunged by more than a third after it admitted that it will be nearly two years late in delivering 75 million doses of recombinant anthrax vaccine to the U.S. government.